Vés al contingut

An Open-Label Extension to Investigate the Long-Term Safety, Tolerability, and Efficacy of DNL310 in Patients With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007

Obert
  • Codi protocol: DNLI-E-0008
  • Codi EudraCT: No aplica
  • Grup de recerca: Neurologia Pediàtrica
  • Servei: Pediatria General i Especialitats
  • Investigador/a principal:  Toro Riera, Mireia del
  • Malaltia: Tumors
  • Fase: Fase III